Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Peringkat dalam Saham #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Harga Saham
$0.00244926
Kapitalisasi Pasar
$51.67K
Perubahan (1 hari)
5.88%
Perubahan (1 tahun)
110.15%
Negara
GB
Perdagangan Nuformix plc (NFX)

Kategori

EPS untuk Nuformix plc (NFX)
EPS per September 2025 TTM: $0.00
Menurut laporan keuangan terbaru dan harga saham Nuformix plc, EPS perusahaan saat ini (TTM) adalah $0.00. Pada akhir 2024, perusahaan memiliki EPS sebesar $-0.01 penurunan dibandingkan dengan EPS tahun 2023 sebesar $0.00.
Riwayat EPS untuk Nuformix plc dari 2014 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
2026 (TTM) 0.00 -100.00%
2025 0.00 -100.00%
2024 $-0.01 520.00%
2023 0.00 -60.00%
2022 0.00 -16.67%
2021 0.00 50.00%
2020 0.00 -57.45%
2019 0.00 -31.88%
2018 $-0.01 -23.33%
2017 $-0.01 8.43%
2016 $-0.01 0.00%
2014 0.00 0.00%
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$3.62 -402,577.78%
DK
$15.47 -1,718,988.89%
US
$43.12 -4,791,211.11%
US
$9.62 -1,069,077.78%
BE
$2.98 -331,211.11%
AU